HK Stock MarketDetailed Quotes

02616 CSTONE PHARMA-B

Watchlist
  • 0.940
  • -0.020-2.08%
Market Closed Mar 28 16:08 CST
1.21BMarket Cap-2974P/E (TTM)

CSTONE PHARMA-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
--79.45M
--1.04B
----
----
----
Operating income
-3.64%463.84M
-0.11%261.47M
97.51%481.36M
229.48%261.77M
-76.54%243.72M
79.45M
1.04B
Cost of sales
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
---31.22M
---241.42M
----
----
----
Operating expenses
21.40%-159.55M
-16.52%-108.04M
-90.00%-202.99M
-197.05%-92.72M
55.75%-106.83M
-31.22M
-241.42M
Gross profit
9.31%304.3M
-9.23%153.44M
103.36%278.38M
250.46%169.04M
-82.83%136.89M
48.23M
797.41M
Selling expenses
39.09%-199.35M
10.19%-131.45M
10.03%-327.3M
-9.56%-146.35M
-155.92%-363.79M
-455.33%-133.58M
---142.15M
---24.06M
----
----
Administrative expenses
26.64%-182.71M
33.84%-89.19M
16.31%-249.06M
12.52%-134.82M
13.11%-297.6M
6.73%-154.11M
-0.30%-342.51M
1.55%-165.23M
-78.79%-341.48M
-350.00%-167.84M
Research and development expenses
14.06%-527.8M
29.95%-186.77M
52.94%-614.16M
48.00%-266.63M
7.10%-1.3B
5.77%-512.75M
-0.65%-1.4B
-41.87%-544.15M
-64.15%-1.4B
24.61%-383.56M
Special items of operating profit
1,293.92%250.15M
151.54%50.62M
120.30%17.95M
203.48%20.12M
30.79%-88.42M
-131.15%-19.45M
77.63%-127.75M
109.12%62.43M
24.06%-571.04M
-245.18%-684.25M
Operating profit
60.25%-355.42M
43.30%-203.35M
53.38%-894.2M
53.52%-358.63M
-57.24%-1.92B
-15.00%-771.65M
47.16%-1.22B
45.70%-671.01M
-28.72%-2.31B
-66.02%-1.24B
Financing cost
-39.42%-11.82M
-100.07%-5.87M
-278.10%-8.48M
-33.64%-2.94M
-69.85%-2.24M
-823.11%-2.2M
-335.64%-1.32M
-59.73%-238K
---303K
---149K
Earning before tax
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
After-tax profit from continuing operations
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
Earning after tax
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-28.74%-2.31B
-66.04%-1.24B
Profit attributable to shareholders
59.32%-367.23M
42.13%-209.23M
52.99%-902.68M
53.28%-361.57M
-57.26%-1.92B
-15.29%-773.85M
47.11%-1.22B
45.68%-671.24M
-32.27%-2.31B
-72.20%-1.24B
Basic earnings per share
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
199.26%1.35
Diluted earnings per share
62.34%-0.29
45.16%-0.17
53.33%-0.77
53.73%-0.31
-41.03%-1.65
-1.52%-0.67
51.05%-1.17
-148.89%-0.66
14.34%-2.39
199.26%1.35
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
Deloitte & Touche Tohmatsu Certified Public Accountants
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover -3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M--79.45M--1.04B------------
Operating income -3.64%463.84M-0.11%261.47M97.51%481.36M229.48%261.77M-76.54%243.72M79.45M1.04B
Cost of sales 21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M---31.22M---241.42M------------
Operating expenses 21.40%-159.55M-16.52%-108.04M-90.00%-202.99M-197.05%-92.72M55.75%-106.83M-31.22M-241.42M
Gross profit 9.31%304.3M-9.23%153.44M103.36%278.38M250.46%169.04M-82.83%136.89M48.23M797.41M
Selling expenses 39.09%-199.35M10.19%-131.45M10.03%-327.3M-9.56%-146.35M-155.92%-363.79M-455.33%-133.58M---142.15M---24.06M--------
Administrative expenses 26.64%-182.71M33.84%-89.19M16.31%-249.06M12.52%-134.82M13.11%-297.6M6.73%-154.11M-0.30%-342.51M1.55%-165.23M-78.79%-341.48M-350.00%-167.84M
Research and development expenses 14.06%-527.8M29.95%-186.77M52.94%-614.16M48.00%-266.63M7.10%-1.3B5.77%-512.75M-0.65%-1.4B-41.87%-544.15M-64.15%-1.4B24.61%-383.56M
Special items of operating profit 1,293.92%250.15M151.54%50.62M120.30%17.95M203.48%20.12M30.79%-88.42M-131.15%-19.45M77.63%-127.75M109.12%62.43M24.06%-571.04M-245.18%-684.25M
Operating profit 60.25%-355.42M43.30%-203.35M53.38%-894.2M53.52%-358.63M-57.24%-1.92B-15.00%-771.65M47.16%-1.22B45.70%-671.01M-28.72%-2.31B-66.02%-1.24B
Financing cost -39.42%-11.82M-100.07%-5.87M-278.10%-8.48M-33.64%-2.94M-69.85%-2.24M-823.11%-2.2M-335.64%-1.32M-59.73%-238K---303K---149K
Earning before tax 59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B
After-tax profit from continuing operations 59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B
Earning after tax 59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-28.74%-2.31B-66.04%-1.24B
Profit attributable to shareholders 59.32%-367.23M42.13%-209.23M52.99%-902.68M53.28%-361.57M-57.26%-1.92B-15.29%-773.85M47.11%-1.22B45.68%-671.24M-32.27%-2.31B-72.20%-1.24B
Basic earnings per share 62.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39199.26%1.35
Diluted earnings per share 62.34%-0.2945.16%-0.1753.33%-0.7753.73%-0.31-41.03%-1.65-1.52%-0.6751.05%-1.17-148.89%-0.6614.34%-2.39199.26%1.35
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--Deloitte & Touche Tohmatsu Certified Public Accountants--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg